We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03347422
Brief Title: A Study to Assess the Efficacy and Safety of BIVV009 (Sutimlimab) in Participants With Primary Cold Agglutinin Disease Without A Recent History of Blood Transfusion (Cadenza)

First Submitted : November 16, 2017
First Submitted that Met QC Criteria : November 16, 2017
First Posted : November 20, 2017

Results First Submitted : December 1, 2022
Results First Submitted that Met QC Criteria : December 1, 2022
Results First Posted : December 23, 2022

Last Update Submitted that Met QC Criteria : December 1, 2022
Last Update Posted : December 23, 2022